Clinical Trials Logo

Clinical Trial Summary

Hypotheses: The primary hypothesis being tested is that there will be no toxicity resulting in loss of vision to no light perception in injected eyes.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02161380
Study type Interventional
Source University of Miami
Contact
Status Active, not recruiting
Phase Phase 1
Start date July 14, 2014
Completion date March 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT01421381 - RHODOS Follow-up Single-visit Study N/A
Completed NCT00747487 - Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy Phase 2
Completed NCT04909398 - Pupil Dynamics and Color Vision for the Detection of Eye Diseases N/A
Completed NCT02693119 - A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy Phase 2
No longer available NCT04381091 - Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the LEROS Study
No longer available NCT02300753 - Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON] N/A
Withdrawn NCT01495715 - Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON) Phase 3